ConductScience.org, home

Trial · NCT06324448

Registered outcomes20

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTimed-up and go test (sec)Immediate post-intervention
PrimaryTimed-up and go test under dual-task condition (sec)Immediate post-intervention
SecondaryDual-task effect (%) in Timed-up and go testImmediate post-intervention
Percentage of dual-task effect calculated by the difference between dual-task and single-task performance \[Percentage of dual-task interference=(Dual-task performance - Single-task performance)/Single-task performance\]
Secondarymodified Attention Allocation Index (mAAI) in Timed-up and go testImmediate post-interventionmodified Attention Allocation Index (mAAI)=motor dual task effect(mDTE)-cognitive dual task effect (cogDTE)
SecondaryGait parametersImmediate post-intervention
Symmetric temporospatial parameters, Normal cadence, Decreased \& intolerable walking velocity, Normal step length differential, Normal step length on both sides, Normal stride length on both sides, Normal swing phase \& stance phase on both sides, Normal single support time \& double support time on both sides, Slightly widened base of support on both sides, Increased foot angle on right side
SecondarySingle-leg stance testImmediate post-intervention
SecondaryStroop testImmediate post-interventionThe Stroop test evaluates attention, executive function, processing speed, and cognitive flexibility regarding an individual's ability to inhibit the habitual response.
SecondaryTrail making testImmediate post-interventionThe trail-making test is a neuropsychological measure that assesses psychomotor speed, attention, sequencing, mental flexibility, and visual scanning.
SecondaryNew freezing of gait questionnaire (NFoGQ)Immediate post-interventionNFoGQ consists of 6 items. Total score ranges from 0 to 24. the higher scores, the more negative results.
SecondaryGeriatric depression scale (GDS)-short formImmediate post-interventionThe GDS Short Form contains 15 items. The higher the score, the more negative the result.
SecondaryTimed-up and go test (sec)Follow-up (1 month)
SecondaryTimed-up and go test under dual-task condition (sec)Follow-up (1 month)
SecondaryDual-task effect (%) in Timed-up and go testFollow-up (1 month)
Percentage of dual-task effect calculated by the difference between dual-task and single-task performance \[Percentage of dual-task interference=(Dual-task performance - Single-task performance)/Single-task performance\]
Secondarymodified Attention Allocation Index (mAAI) in Timed-up and go testFollow-up (1 month)modified Attention Allocation Index (mAAI)=motor dual task effect(mDTE)-cognitive dual task effect (cogDTE)
SecondaryGait parametersFollow-up (1 month)
Symmetric temporospatial parameters, Normal cadence, Decreased \& intolerable walking velocity, Normal step length differential, Normal step length on both sides, Normal stride length on both sides, Normal swing phase \& stance phase on both sides, Normal single support time \& double support time on both sides, Slightly widened base of support on both sides, Increased foot angle on right side
SecondarySingle-leg stance testFollow-up (1 month)
SecondaryStroop testFollow-up (1 month)The Stroop test evaluates attention, executive function, processing speed, and cognitive flexibility regarding an individual's ability to inhibit the habitual response.
SecondaryTrail making testFollow-up (1 month)The trail-making test is a neuropsychological measure that assesses psychomotor speed, attention, sequencing, mental flexibility, and visual scanning.
SecondaryNew freezing of gait questionnaire (NFoGQ)Follow-up (1 month)NFoGQ consists of 6 items. Total score ranges from 0 to 24. the higher scores, the more negative results.
SecondaryGeriatric depression scale (GDS)-short formFollow-up (1 month)The GDS Short Form contains 15 items. The higher the score, the more negative the result.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06324448/registered